He has developed a microchip to capture extremely rare circulating tumor cells (CTCs) in cancer patients. This technology promises to diagnose cancer earlier and to monitor and guide treatment. Scientists have tried for decades to isolate these cells, which circulate at a rate of one in a billion cells. In the future, when the CTC chip becomes clinically available, a blood sample will be enough to detect cancer cells long before a tumor recurs.
You are using an unsupported browser. Please use the latest version of
Chrome, Firefox, Safari or Edge.
Support the MGH Fund
Don't wait! Double your impact now - make your gift to the MGH Fund today, and it will be matched dollar-for-dollar.
Giving Tuesday starts in:
